US pharma giant seeks marketing authorisation from India for remdesivir

"Gilead Sciences has applied seeking marketing authorisation for its anti-viral drug remdesivir to India's Central Drugs Standard Control Organisation (CDSCO). The CDSCO will examine the application with the help of the expert committee. It will take a final decision based on the recommendations of the expert committee," a source said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2ApxrI1
via IFTTT